[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @PersimmonTI Persimmon Tree Investments Persimmon Tree Investments posts on X about $xbi, $srpt, $lly, $nvs the most. They currently have XXXXX followers and 1387 posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::4496252499/interactions)  - X Week XXXXXX -XX% - X Month XXXXXXX -XX% - X Months XXXXXXXXX +120% - X Year XXXXXXXXX +163% ### Mentions: XX [#](/creator/twitter::4496252499/posts_active)  - X Week XX -XXXX% - X Month XXX -XX% - X Months XXX +130% - X Year XXXXX +325% ### Followers: XXXXX [#](/creator/twitter::4496252499/followers)  - X Week XXXXX +0.50% - X Month XXXXX +1.60% - X Months XXXXX +8% - X Year XXXXX +17% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::4496252499/influencer_rank)  ### Social Influence [#](/creator/twitter::4496252499/influence) --- **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [currencies](/list/currencies) [countries](/list/countries) [technology brands](/list/technology-brands) [cryptocurrencies](/list/cryptocurrencies) **Social topic influence** [$xbi](/topic/$xbi), [$srpt](/topic/$srpt), [$lly](/topic/$lly), [$nvs](/topic/$nvs), [$azn](/topic/$azn), [$alny](/topic/$alny), [$bbio](/topic/$bbio), [$mtsr](/topic/$mtsr), [$vrna](/topic/$vrna), [$mrk](/topic/$mrk) **Top assets mentioned** [Bitcoin Incognito (XBI)](/topic/$xbi) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Eli Lilly and Company (LLY)](/topic/$lly) [Novartis AG (NVS)](/topic/$nvs) [AstraZeneca PLC (AZN)](/topic/$azn) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Johnson & Johnson (JNJ)](/topic/$jnj) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Arcellx, Inc. Common Stock (ACLX)](/topic/$aclx) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Pfizer, Inc. (PFE)](/topic/$pfe) [SuperRare (RARE)](/topic/$rare) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Novo-Nordisk (NVO)](/topic/$nvo) [AbbVie Inc (ABBV)](/topic/$abbv) [Goldman Sachs (GS)](/topic/goldman-sachs) ### Top Social Posts [#](/creator/twitter::4496252499/posts) --- Top posts by engagements in the last XX hours "$LLY The power of $LLY imagination on continued display courtesy @NatureBiotech:"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1945998810255077529) 2025-07-18 00:07:25 UTC 9537 followers, 2086 engagements "$KROS Just your share dollars at work here for low to moderate risk MDS are they not at all sheepish"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1945818698092101724) 2025-07-17 12:11:43 UTC 9532 followers, 1347 engagements "$NVS x $KDNY Alleged Insider trading by a former $KDNY board member who himself traded on information about $NVS buyout as well as tipped off X others about the news. All too human I guess"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1929203816127181107) 2025-06-01 15:50:07 UTC 9538 followers, 2083 engagements "Seems like a good time to remind folks that $SRPT and $SAVA share a key board member"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1946026114431746155) 2025-07-18 01:55:55 UTC 9531 followers, 4289 engagements "$SRPT It seems that $SRPT has censored portions of Friday nights LGMD analyst Q&A call recording. Potentially among other portions the very direct (near confrontational) question from analyst (to which I refer as Analyst Z in quoted tweet below) no longer appears in the call recording. Recall that last summer STAT reported that $SRPT had demanded that PPMD remove portions of annual conference video in which a parent offered sharp criticism of the companys practices. And recall the WSJ report from back in 2017 reporting that $SRPT through consultant had heavily coached parents FDA testimony"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1946962020361760965) 2025-07-20 15:54:53 UTC 9533 followers, 4314 engagements "$XBI $GILD $BMY $JNJ $ACLX $LEGN $AUTL A clear positive from the FDA taking action on its promise to expand/speed access to meaningful Tx: FDA removing REMS and other onerous requirements for the administration of BCMA and CD19 targeting CAR-T which should lower the cost & administrative burden of CAR-T and pave the way for more community-based admin of CAR-T. Again a significant positive sign from the FDA and from Prasads CBER no less that may turn the tide and improve upon the currently underutilized Tx getting CAR-T to more patients who are eligible for it and could benefit from it:"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1939112125412106650) 2025-06-29 00:02:12 UTC 9538 followers, 6946 engagements "@Biohazard3737 Ask ChatGPT to reply as if it were Grok"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1946026831963894259) 2025-07-18 01:58:46 UTC 9532 followers, 1134 engagements "$SRPT And the award for longest PR goes to quite a lot in there:"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1945806586301071364) 2025-07-17 11:23:36 UTC 9538 followers, 7953 engagements "$SMMT $AZN $xbi The PD1xVEGF state of play Bloomberg story re: ongoing discussion between $AZN and $SMMT for partnership would make a lot of sense for both parties. Had previously guessed a major rights partnering for Duggans $SMMT could be in the cards though I hadnt mentioned $AZN. Though questions remain re: ivonescimab survival advantage over pembro pharma is beyond the merely hedging their bets stage now. The stakes are too high if PD1xVEGF is the real deal. $MRK Dean Li was instructive at Goldman Sachs last month sharing the Mercks strategy was to advance pembro and their PD1xVEGF"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1941562290974700019) 2025-07-05 18:18:17 UTC 9538 followers, 6340 engagements "$XBI Orphaned No More $RARE / $MREO $SRRK $BBIO $ALNY $RCKT $BMRN Below the final language of the Orphan exclusivity expansion language that passed as part of the final megabill. Note that in addition to Medicare price negotiation exemption being extended to Tx that treat multiple rare disease indications rare disease Tx would have a delayed start to the price negotiation countdown if the reason it lost exemption was that a non-rare-disease indication had been added to its label. Playing this out with a specific hypothetical $RARE / $MREO Setrusumab we can see how these provisions could have"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1941684242066358445) 2025-07-06 02:22:52 UTC 9538 followers, 12K engagements "$MTSR continues to trade like something is up 🤔 🧐"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1945123014913180067) 2025-07-15 14:07:20 UTC 9537 followers, 2117 engagements "$LLY $xbi Anyone catch $LLY subtle flex at Goldman They noted that they were cautious about late stage/commercial $XBI M&A because it might lead to net deceleration of their sales growth rate 😂"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1944506807256301603) 2025-07-13 21:18:44 UTC 9538 followers, 2166 engagements "$XBI Select amylins in clinic courtesy @Nature Metabolism. Note that $MTSR not included and its and $GPCR are currently unattached to big pharma"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1944875375584272744) 2025-07-14 21:43:18 UTC 9538 followers, 4072 engagements "$BBIO $ALNY $BBIO CEO at Goldman Sachs: I mean were basically generic as compared to AMVUTTRA"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1941896696021086400) 2025-07-06 16:27:05 UTC 9534 followers, 4102 engagements "$NVS $xbi Novartis on capital allocation and M&A yesterday - not prioritizing dividend/buybacks over M&A - no recent M&A is not for lack of trying - $XX billion in firepower $NVS always looking for bolt-on acquisitions and maybe larger bolt-ons () that would bolster its focus TAs"  [@PersimmonTI](/creator/x/PersimmonTI) on [X](/post/tweet/1946164533711745163) 2025-07-18 11:05:57 UTC 9538 followers, 4544 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@PersimmonTI Persimmon Tree Investments
Persimmon Tree Investments posts on X about $xbi, $srpt, $lly, $nvs the most. They currently have XXXXX followers and 1387 posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXXX -XX%
- X Month XXXXXXX -XX%
- X Months XXXXXXXXX +120%
- X Year XXXXXXXXX +163%
Mentions: XX #
- X Week XX -XXXX%
- X Month XXX -XX%
- X Months XXX +130%
- X Year XXXXX +325%
Followers: XXXXX #
- X Week XXXXX +0.50%
- X Month XXXXX +1.60%
- X Months XXXXX +8%
- X Year XXXXX +17%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks finance currencies countries technology brands cryptocurrencies
Social topic influence $xbi, $srpt, $lly, $nvs, $azn, $alny, $bbio, $mtsr, $vrna, $mrk
Top assets mentioned Bitcoin Incognito (XBI) Sarepta Therapeutics, Inc. (SRPT) Eli Lilly and Company (LLY) Novartis AG (NVS) AstraZeneca PLC (AZN) Alnylam Pharmaceuticals, Inc. (ALNY) BridgeBio Pharma, Inc. Common Stock (BBIO) Metsera, Inc. Common Stock (MTSR) Merck & Co., Inc. (MRK) Dyne Therapeutics, Inc. Common Stock (DYN) Avidity Biosciences, Inc. Common Stock (RNA) Johnson & Johnson (JNJ) Gilead Sciences, Inc. (GILD) Bristol-Myers Squibb Co (BMY) Arcellx, Inc. Common Stock (ACLX) Summit Therapeutics Inc. Common Stock (SMMT) Pfizer, Inc. (PFE) SuperRare (RARE) Scholar Rock Holding Corporation Common Stock (SRRK) BioMarin Pharmaceutical, Inc. (BMRN) Novo-Nordisk (NVO) AbbVie Inc (ABBV) Goldman Sachs (GS)
Top Social Posts #
Top posts by engagements in the last XX hours
"$LLY The power of $LLY imagination on continued display courtesy @NatureBiotech:"
@PersimmonTI on X 2025-07-18 00:07:25 UTC 9537 followers, 2086 engagements
"$KROS Just your share dollars at work here for low to moderate risk MDS are they not at all sheepish" @PersimmonTI on X 2025-07-17 12:11:43 UTC 9532 followers, 1347 engagements
"$NVS x $KDNY Alleged Insider trading by a former $KDNY board member who himself traded on information about $NVS buyout as well as tipped off X others about the news. All too human I guess" @PersimmonTI on X 2025-06-01 15:50:07 UTC 9538 followers, 2083 engagements
"Seems like a good time to remind folks that $SRPT and $SAVA share a key board member" @PersimmonTI on X 2025-07-18 01:55:55 UTC 9531 followers, 4289 engagements
"$SRPT It seems that $SRPT has censored portions of Friday nights LGMD analyst Q&A call recording. Potentially among other portions the very direct (near confrontational) question from analyst (to which I refer as Analyst Z in quoted tweet below) no longer appears in the call recording. Recall that last summer STAT reported that $SRPT had demanded that PPMD remove portions of annual conference video in which a parent offered sharp criticism of the companys practices. And recall the WSJ report from back in 2017 reporting that $SRPT through consultant had heavily coached parents FDA testimony" @PersimmonTI on X 2025-07-20 15:54:53 UTC 9533 followers, 4314 engagements
"$XBI $GILD $BMY $JNJ $ACLX $LEGN $AUTL A clear positive from the FDA taking action on its promise to expand/speed access to meaningful Tx: FDA removing REMS and other onerous requirements for the administration of BCMA and CD19 targeting CAR-T which should lower the cost & administrative burden of CAR-T and pave the way for more community-based admin of CAR-T. Again a significant positive sign from the FDA and from Prasads CBER no less that may turn the tide and improve upon the currently underutilized Tx getting CAR-T to more patients who are eligible for it and could benefit from it:" @PersimmonTI on X 2025-06-29 00:02:12 UTC 9538 followers, 6946 engagements
"@Biohazard3737 Ask ChatGPT to reply as if it were Grok" @PersimmonTI on X 2025-07-18 01:58:46 UTC 9532 followers, 1134 engagements
"$SRPT And the award for longest PR goes to quite a lot in there:" @PersimmonTI on X 2025-07-17 11:23:36 UTC 9538 followers, 7953 engagements
"$SMMT $AZN $xbi The PD1xVEGF state of play Bloomberg story re: ongoing discussion between $AZN and $SMMT for partnership would make a lot of sense for both parties. Had previously guessed a major rights partnering for Duggans $SMMT could be in the cards though I hadnt mentioned $AZN. Though questions remain re: ivonescimab survival advantage over pembro pharma is beyond the merely hedging their bets stage now. The stakes are too high if PD1xVEGF is the real deal. $MRK Dean Li was instructive at Goldman Sachs last month sharing the Mercks strategy was to advance pembro and their PD1xVEGF" @PersimmonTI on X 2025-07-05 18:18:17 UTC 9538 followers, 6340 engagements
"$XBI Orphaned No More $RARE / $MREO $SRRK $BBIO $ALNY $RCKT $BMRN Below the final language of the Orphan exclusivity expansion language that passed as part of the final megabill. Note that in addition to Medicare price negotiation exemption being extended to Tx that treat multiple rare disease indications rare disease Tx would have a delayed start to the price negotiation countdown if the reason it lost exemption was that a non-rare-disease indication had been added to its label. Playing this out with a specific hypothetical $RARE / $MREO Setrusumab we can see how these provisions could have" @PersimmonTI on X 2025-07-06 02:22:52 UTC 9538 followers, 12K engagements
"$MTSR continues to trade like something is up 🤔 🧐" @PersimmonTI on X 2025-07-15 14:07:20 UTC 9537 followers, 2117 engagements
"$LLY $xbi Anyone catch $LLY subtle flex at Goldman They noted that they were cautious about late stage/commercial $XBI M&A because it might lead to net deceleration of their sales growth rate 😂" @PersimmonTI on X 2025-07-13 21:18:44 UTC 9538 followers, 2166 engagements
"$XBI Select amylins in clinic courtesy @Nature Metabolism. Note that $MTSR not included and its and $GPCR are currently unattached to big pharma" @PersimmonTI on X 2025-07-14 21:43:18 UTC 9538 followers, 4072 engagements
"$BBIO $ALNY $BBIO CEO at Goldman Sachs: I mean were basically generic as compared to AMVUTTRA" @PersimmonTI on X 2025-07-06 16:27:05 UTC 9534 followers, 4102 engagements
"$NVS $xbi Novartis on capital allocation and M&A yesterday - not prioritizing dividend/buybacks over M&A - no recent M&A is not for lack of trying - $XX billion in firepower $NVS always looking for bolt-on acquisitions and maybe larger bolt-ons () that would bolster its focus TAs" @PersimmonTI on X 2025-07-18 11:05:57 UTC 9538 followers, 4544 engagements